| (2S,5S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid |
(2S,5S)-N-Boc-5-甲基吡咯烷-2-甲酸 |
334769-80-1 |
| N-Methyl-4-chloropyridine-2-carboxamide |
N-甲基-4-氯-2-吡啶甲酰胺 |
220000-87-3 |
| N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester |
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷酰基]-L-丙氨酸异丙酯 |
1334513-02-8 |
| WZ4002 |
WZ4002 |
1213269-23-8 |
| 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)- |
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-74-2 |
| ledipasvir interMediate |
(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-87-7 |
| cis-2-fluorocyclopropylaminetosylate |
141042-21-9 |
141042-21-9 |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
利拉利汀母核 |
853029-57-9 |
| 4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE |
4-(1H-吡唑-4-基)-7-((2-(三甲基硅烷基)乙氧基)-甲基)-7H-吡咯并[2,3-D]嘧啶 |
941685-27-4 |
| Lumacaftor (VX-809) |
鲁玛卡托 |
936727-05-8 |
| 3-Ethynylimidazo[1,2-b]pyridazine |
3-炔基咪唑[1,2-B]哒嗪 |
943320-61-4 |
| BenzaMide, 3-iodo-4-Methyl-N-[4-[(4-Methyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]- |
3-碘-4-甲基-N-[4-[(4-甲基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]苯甲酰胺 |
943320-50-1 |
| Dovitinib |
多韦替尼 |
915769-50-5 |
| 2,4-Dichloro-5-methoxyaniline |
2,4-二氯-5-甲氧基苯胺 |
98446-49-2 |
| 1H-PYRROLO[2,3-B]PYRIDIN-5-OL |
1H-吡咯并[2,3-B]吡啶-5-醇 |
98549-88-3 |
| 1-CYCLOPROPYL-6,7-DIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID |
1-环丙基-6,7-二氟-1,4-二氢-4-氧代-3-喹啉甲酸 |
93107-30-3 |
| 4-Chloro-3-nitrobenzonitrile |
4-氯-3-硝基苯甲腈 |
939-80-0 |
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl |
利伐沙班中间体 |
898543-06-1 |
| (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
[5-溴-3-[(1R)-(2,6-二氯-3-氟苯基)乙氧基]吡啶-2-基]胺 |
877399-00-3 |
| Crizotinib |
克唑替尼 |
877399-52-5 |
